4.6 Review

Clinical and Scientific Perspectives on Movement Disorders: Stanley Fahn's Contributions

期刊

MOVEMENT DISORDERS
卷 30, 期 14, 页码 1862-1869

出版社

WILEY
DOI: 10.1002/mds.26445

关键词

Parkinson's disease; dystonia; tremor; tics; myoclonus; tardive dyskinesia

资金

  1. National Parkinson Foundation

向作者/读者索取更多资源

Dr. Stanley Fahn, the H. Houston Merritt Professor of Neurology and Director Emeritus of the Center for Parkinson's Disease and Other Movement Disorders at Columbia University, one of the founders of the field of movement disorders, was the first president of the Movement Disorders Society (subsequently renamed as the International Parkinson and Movement Disorder Society). Together with his friend and colleague, Professor David Marsden, he also served as the first co-editor of the journal Movement Disorders. By emphasizing phenomenology as the key element in differentiating various hypokinetic and hyperkinetic movement disorders, Dr. Fahn drew attention to the clinical history and the power of observation in the diagnosis of movement disorders. Dr. Fahn had major influence on the development of classifications and assessments of various movement disorders and in organizing various research groups such as the Parkinson Study Group. As the founder and president of the World Parkinson Coalition and an organizer of the initial three World Parkinson Congresses, he has demonstrated his long-standing commitment to the cause of including patients as partners. The primary goal and objective of this invited review is to highlight some of Dr. Fahn's most impactful scientific and clinical contributions to the understanding and treatment of Parkinson's disease, dystonia, and other movement disorders. (C) 2015 International Parkinson and Movement Disorder Society

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in mice

Myoung Seok Ko, Ji Young Yun, In-Jeoung Baek, Jung Eun Jang, Jung Jin Hwang, Seung Eun Lee, Seung-Ho Heo, David A. Bader, Chul-Ho Lee, Jaeseok Han, Jong-Seok Moon, Jae Man Lee, Eun-Gyoung Hong, In-Kyu Lee, Seong Who Kim, Joong Yeol Park, Sean M. Hartig, Un Jung Kang, David D. Moore, Eun Hee Koh, Ki-up Lee

Summary: This study revealed the role of a specific gene, pink1, in mitochondrial autophagy, where its deficiency induces dysfunction in brown adipose tissue and obesity. Surprisingly, the induction of NLRP3 did not lead to canonical inflammasome activity, but instead caused brown adipocyte precursors to differentiate into white-like adipocytes. These findings suggest a new mitochondria-NLRP3 pathway that contributes to BAT dysfunction and provide potential therapeutic targets for obesity-related metabolic diseases.

AUTOPHAGY (2021)

Article Clinical Neurology

Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders

Stella M. Papa, Patrik Brundin, Victor S. C. Fung, Un Jung Kang, David J. Burn, Carlo Colosimo, Han-Lin Chiang, Roy N. Alcalay, Claudia Trenkwalder

MOVEMENT DISORDERS (2020)

Article Clinical Neurology

Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells ofLeucine-RichRepeat Kinase 2G2019SCarriers: A NovelEnzyme-LinkedImmunosorbent Assay-Based Method

Katerina Melachroinou, Min Suk Kang, Christopher Liong, Sushma Narayan, Najah Levers, Neal Joshi, Katie Kopil, Samantha J. Hutten, Marco A. S. Baptista, Shalini Padmanabhan, Un Jung Kang, Leonidas Stefanis, Roy N. Alcalay, Hardy J. Rideout

MOVEMENT DISORDERS (2020)

Article Clinical Neurology

A rapid α-synuclein seed assay of Parkinson's disease CSF panel shows high diagnostic accuracy

Christina D. Orru, Thong C. Ma, Andrew G. Hughson, Bradley R. Groveman, Ankit Srivastava, Douglas Galasko, Rachel Angers, Patrick Downey, Karen Crawford, Samantha J. Hutten, Un Jung Kang, Byron Caughey

Summary: The study shows that an improved assay for diagnosing Parkinson's disease dramatically reduces the diagnosis time while maintaining high performance standards. Positive signals were found in 97% of Parkinson's disease cases compared to only 13% of healthy controls, with weak correlations between assay parameters and clinical measures observed. The assay's efficiency in diagnosing Parkinson's disease is supported by these findings.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Editorial Material Neurosciences

COVID-19 Vaccination for Persons with Parkinson's Disease: Light at the End of the Tunnel?

Bastiaan R. Bloem, Claudia Trenkwalder, Alvaro Sanchez-Ferro, Lorraine V. Kalia, Roy Alcalay, Han-Lin Chiang, Un Jung Kang, Christopher Goetz, Patrik Brundin, Stella M. Papa

Summary: Despite concerns raised by people with Parkinson's disease (PD) and their physicians regarding the efficacy and safety of COVID-19 vaccines in the specific context of PD and its treatment, current literature and experience with widespread vaccination suggest that COVID-19 vaccination with approved vaccines is recommended for PD patients, unless there is a specific contraindication.

JOURNAL OF PARKINSONS DISEASE (2021)

Article Clinical Neurology

α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy

Suman Dutta, Simon Hornung, Adira Kruayatidee, Katherine N. Maina, Irish del Rosario, Kimberly C. Paul, Darice Y. Wong, Aline Duarte Folle, Daniela Markovic, Jose-Alberto Palma, Geidy E. Serrano, Charles H. Adler, Susan L. Perlman, Wayne W. Poon, Un Jung Kang, Roy N. Alcalay, Miriam Sklerov, Karen H. Gylys, Horacio Kaufmann, Brent L. Fogel, Jeff M. Bronstein, Beate Ritz, Gal Bitan

Summary: The study found that measuring α-syn in exosomes from blood can effectively distinguish between patients with PD and MSA with high sensitivity and specificity. A multinomial logistic model combining α-syn concentration, exosome concentration, and a ratio between α-syn concentrations in specific exosomes showed promising results in separating PD from MSA.

ACTA NEUROPATHOLOGICA (2021)

Article Medicine, Research & Experimental

TorsinA restoration in a mouse model identifies a critical therapeutic window for DYT1 dystonia

Jay Li, Daniel S. Levin, Audrey J. Kim, Samuel S. Pappas, William T. Dauer

Summary: Research in a mouse model of DYT1 dystonia showed a critical requirement for torsinA in normal motor function and gene therapy, with a particular emphasis on its essential role during a developmental critical period. These findings suggest that torsinA-based therapeutic strategies need to be employed early in the course of DYT1 dystonia for effectiveness.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Correction Clinical Neurology

α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy (May, 10.1007/s00401-021-02324-0, 2021)

Suman Dutta, Simon Hornung, Adira Kruayatidee, Katherine N. Maina, Irish del Rosario, Kimberly C. Paul, Darice Y. Wong, Aline Duarte Folle, Daniela Markovic, Jose-Alberto Palma, Geidy E. Serrano, Charles H. Adler, Susan L. Perlman, Wayne W. Poon, Un Jung Kang, Roy N. Alcalay, Miriam Sklerov, Karen H. Gylys, Horacio Kaufmann, Brent L. Fogel, Jeff M. Bronstein, Beate Ritz, Gal Bitan

Summary: A correction to the paper has been published.

ACTA NEUROPATHOLOGICA (2021)

Letter Clinical Neurology

Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression

Luis Concha-Marambio, Carly M. Farris, Bret Holguin, Yihua Ma, John Seibyl, Marco J. Russo, Un J. Kang, Samantha J. Hutten, Kalpana Merchant, Mohammad Shahnawaz, Claudio Soto

MOVEMENT DISORDERS (2021)

Article Multidisciplinary Sciences

THAP1 modulates oligodendrocyte maturation by regulating ECM degradation in lysosomes

Dhananjay Yellajoshyula, Samuel S. Pappas, Abigail E. Rogers, Biswa Choudhury, Xylena Reed, Jinhui Ding, Mark R. Cookson, Vikram G. Shakkottai, Roman J. Giger, William T. Dauer

Summary: THAP1 regulates myelination initiation by modulating GAG catabolism and ECM composition, with a lack of THAP1 leading to excess GAG accumulation and inhibition of OL maturation.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Clinical Neurology

Oligodendrocyte and Extracellular Matrix Contributions to Central Nervous System Motor Function: Implications for Dystonia

Dhananjay Yellajoshyula, Samuel S. Pappas, William T. Dauer

Summary: The development of genomics and neuroimaging techniques has shed light on the importance of neuronal-glial interactions and extracellular matrix in nervous system development, function, and plasticity. Abnormalities in neuronal-glial interactions play a key role in neurodevelopmental disorders.

MOVEMENT DISORDERS (2022)

Article Biochemistry & Molecular Biology

Hepatocytes Deficient in Nuclear Envelope Protein Lamina-associated Polypeptide 1 are an Ideal Mammalian System to Study Intranuclear Lipid Droplets

Cecilia Ostlund, Antonio Hernandez-Ono, Samantha J. Turk, William T. Dauer, Henry N. Ginsberg, Howard J. Worman, Ji-Yeon Shin

Summary: In this study, the occurrence of nuclear lipid droplets (LDs) in primary hepatocytes from mice following depletion of lamina-associated polypeptide 1 (LAP1) was investigated. The results revealed that LAP1-depleted hepatocytes contain frequent nuclear LDs, which differ from cytoplasmic LDs in their associated proteins. The study also demonstrated a relationship of LD formation with nutritional state.

JOURNAL OF LIPID RESEARCH (2022)

Article Neurosciences

Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson's disease phenotypes

Giulietta Maria Riboldi, Marco J. Russo, Ling Pan, Kristen Watkins, Un Jung Kang

Summary: Non-motor symptoms like dysautonomia and REM sleep behavior disorder in Parkinson's disease may indicate different types of the disease. Through analysis of data from newly diagnosed Parkinson's patients, it was found that dysautonomia symptoms can predict disease progression more accurately.

NPJ PARKINSONS DISEASE (2022)

Correction Neurosciences

Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson's disease phenotypes (vol 8, 110, 2022)

Giulietta Maria Riboldi, Marco J. Russo, Ling Pan, Kristen Watkins, Un Jung Kang

NPJ PARKINSONS DISEASE (2023)

Article Clinical Neurology

Substantia Nigra Pars Reticulata Projections to the Pedunculopontine Nucleus Modulate Dyskinesia

Yong Hu, Thong C. Ma, Stephanie L. Alberico, Yunmin Ding, Lingjing Jin, Un Jung Kang

Summary: This study aimed to determine whether direct modulation of SNr GABAergic neurons and SNr projections to the PPN can regulate PD symptoms and levodopa-induced dyskinesia (LID). The results showed that suppressing SNr neuron activity improved akinesia, while increasing SNr neuronal activity significantly reduced LID. The projections from SNr to PPN likely mediate the antidyskinetic effect of increasing SNr neuronal activity.

MOVEMENT DISORDERS (2023)

暂无数据